BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8791485)

  • 1. Recent advances in tumor necrosis factor and CD40 signaling.
    Tewari M; Dixit VM
    Curr Opin Genet Dev; 1996 Feb; 6(1):39-44. PubMed ID: 8791485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TNF receptor-associated factor 2 in the activation of IgM secretion by CD40 and CD120b.
    Hostager BS; Bishop GA
    J Immunol; 2002 Apr; 168(7):3318-22. PubMed ID: 11907088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.
    Rothe M; Sarma V; Dixit VM; Goeddel DV
    Science; 1995 Sep; 269(5229):1424-7. PubMed ID: 7544915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2.
    Kieser A; Kaiser C; Hammerschmidt W
    EMBO J; 1999 May; 18(9):2511-21. PubMed ID: 10228165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
    Borghi A; Verstrepen L; Beyaert R
    Biochem Pharmacol; 2016 Sep; 116():1-10. PubMed ID: 26993379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
    Twu YC; Gold MR; Teh HS
    Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses.
    Nguyen LT; Duncan GS; Mirtsos C; Ng M; Speiser DE; Shahinian A; Marino MW; Mak TW; Ohashi PS; Yeh WC
    Immunity; 1999 Sep; 11(3):379-89. PubMed ID: 10514016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization.
    Gaeta ML; Johnson DR; Kluger MS; Pober JS
    Lab Invest; 2000 Aug; 80(8):1185-94. PubMed ID: 10950109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25.
    Li Y; Sheng K; Chen J; Wu Y; Zhang F; Chang Y; Wu H; Fu J; Zhang L; Wei W
    Eur J Pharmacol; 2015 Dec; 769():8-21. PubMed ID: 26415983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
    Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
    Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes.
    Chan FK; Lenardo MJ
    Eur J Immunol; 2000 Feb; 30(2):652-60. PubMed ID: 10671223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
    Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
    Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation.
    Wicovsky A; Henkler F; Salzmann S; Scheurich P; Kneitz C; Wajant H
    Oncogene; 2009 Apr; 28(15):1769-81. PubMed ID: 19287455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation.
    Hsu H; Xiong J; Goeddel DV
    Cell; 1995 May; 81(4):495-504. PubMed ID: 7758105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor.
    Adam-Klages S; Schwandner R; Adam D; Kreder D; Bernardo K; Krönke M
    J Leukoc Biol; 1998 Jun; 63(6):678-82. PubMed ID: 9620659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway.
    Tsao DH; McDonagh T; Telliez JB; Hsu S; Malakian K; Xu GY; Lin LL
    Mol Cell; 2000 Jun; 5(6):1051-7. PubMed ID: 10911999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of nuclear factor-kappaB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorly.
    McFarlane SM; Pashmi G; Connell MC; Littlejohn AF; Tucker SJ; Vandenabeele P; MacEwan DJ
    FEBS Lett; 2002 Mar; 515(1-3):119-26. PubMed ID: 11943206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40-CD40 ligand: a multifunctional receptor-ligand pair.
    Van Kooten C; Banchereau J
    Adv Immunol; 1996; 61():1-77. PubMed ID: 8834494
    [No Abstract]   [Full Text] [Related]  

  • 19. Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats.
    Misaki T; Yamamoto T; Suzuki S; Fukasawa H; Togawa A; Ohashi N; Suzuki H; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Kitagawa M; Hishida A
    Am J Pathol; 2009 Jul; 175(1):74-83. PubMed ID: 19541932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors.
    Feng X; Gaeta ML; Madge LA; Yang JH; Bradley JR; Pober JS
    J Biol Chem; 2001 Mar; 276(11):8341-9. PubMed ID: 11112773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.